We are live on
!
Find out more
DIM
DC Investments Management Portfolio holdings
AUM
$261M
1-Year Est. Return
20.71%
This Fund
S&P 500
This Quarter
Est. Return
+2.77%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$20.7M
(+13%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
12.03%
Top 10 Holdings %
Top 10 Hldgs %
19.42%
Holding
389
New
143
Increased
37
Reduced
121
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Par Pacific Holdings
PARR
|
+$9.97M |
| 2 |
Evolent Health
EVH
|
+$2.15M |
| 3 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$850K |
| 4 |
Milestone Pharmaceuticals
MIST
|
+$805K |
| 5 |
Zoom
ZM
|
+$796K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Westlake Corp
WLK
|
+$1.74M |
| 2 |
Darden Restaurants
DRI
|
+$1.51M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$1.45M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$1.32M |
| 5 |
Prudential Financial
PRU
|
+$1.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.73% |
| 2 | Financials | 12.84% |
| 3 | Technology | 12.57% |
| 4 | Energy | 11.53% |
| 5 | Utilities | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Par Pacific Holdings
PARR
$4.17B
| $10.5M | 5.87% |
+511,378
| New | +$9.97M |
|
2
Chemours
CC
$2.48B
| $8.61M | 4.82% |
358,782
| – | – |
|
3
Delek US
DK
$3.98B
| $5.67M | 3.17% |
139,880
| – | – |
|
4
Alcoa
AA
$11.3B
| $3.32M | 1.86% |
141,959
| – | – |
|
|
5
Evolent Health
EVH
$371M
| $1.44M | 0.81% |
+181,598
| New | +$2.15M |
|
6
Medtronic
MDT
$112B
| $1.1M | 0.61% |
11,254
+374
| +3% | +$34.1K |
|
|
7
Milestone Pharmaceuticals
MIST
$129M
| $1.06M | 0.59% |
+39,038
| New | +$805K |
|
8
Sanofi
SNY
$107B
| $1M | 0.56% |
23,112
| – | – |
|
9
Steris
STE
$22.9B
| $997K | 0.56% |
6,698
-2,487
| -27% | -$332K |
|
10
Novartis
NVS
$302B
| $993K | 0.56% |
10,876
+544
| +5% | +$46K |
|
11
Smith & Nephew
SNN
$13.7B
| $993K | 0.56% |
22,815
-4,587
| -17% | -$190K |
|
12
Accenture
ACN
$106B
| $956K | 0.54% |
5,172
-1,382
| -21% | -$248K |
|
13
Coca-Cola Europacific Partners
CCEP
$49.1B
| $947K | 0.53% |
16,766
+4,786
| +40% | +$262K |
|
|
CBLK
14
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $926K | 0.52% |
+55,369
| New | +$850K |
|
15
GSK
GSK
$107B
| $910K | 0.51% |
18,198
-3,303
| -15% | -$166K |
|
|
NVO
16
Novo Nordisk
NVO
$228B
| $882K | 0.49% |
34,552
-6,698
| -16% | -$166K |
|
17
Goldman Sachs
GS
$289B
| $866K | 0.48% |
4,235
-974
| -19% | -$193K |
|
|
18
Zoom
ZM
$27.1B
| $859K | 0.48% |
+9,677
| New | +$796K |
|
19
AstraZeneca
AZN
$269B
| $853K | 0.48% |
10,327
| – | – |
|
|
TPTX
20
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $845K | 0.47% |
+20,761
| New | +$741K |
|
21
Rapid7
RPD
$628M
| $827K | 0.46% |
+14,294
| New | +$752K |
|
22
Avantor
AVTR
$9.82B
| $790K | 0.44% |
+41,379
| New | +$737K |
|
23
Transmedics
TMDX
$2.7B
| $778K | 0.44% |
+26,834
| New | +$733K |
|
24
Quince Therapeutics
QNCX
$21.5M
| $776K | 0.43% |
+91
| New | +$544K |
|
|
CARB
25
DELISTED
Carbonite Inc
CARB
| $775K | 0.43% |
+29,764
| New | +$727K |
|
Similar funds
DC
AFC
TIG
GTAM
MCS
NG
ICM
LCM
DC Investments Management's Q2 2019 Portfolio in Review
As of Q2 2019, DC Investments Management held 389 positions worth $179M, up 13% from $158M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DC Investments Management deployed $21.5M of net new capital in Q2 2019, opening 143 new positions and adding to 37 existing holdings. Its largest new stake was Par Pacific Holdings: 511,378 shares worth $10.5M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was UnitedHealth, an estimated $665K trimmed.
- DC Investments Management's largest Q2 2019 buy was Par Pacific Holdings: 511,378 shares worth $10.5M.
- DC Investments Management added most to NextEra Energy in Q2 2019, an estimated $293K increase.
- DC Investments Management's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $665K.
- DC Investments Management fully exited Westlake Corp in Q2 2019, selling an estimated $1.74M.
- DC Investments Management's ten largest holdings make up 19% of its $179M portfolio in Q2 2019.
- DC Investments Management opened 143 new positions and closed 64 in Q2 2019.
- DC Investments Management's portfolio value rose 13% quarter-over-quarter to $179M.
Based on DC Investments Management's 13F filing for Q2 2019, filed 12 Aug 2019.